BusinessCellular Biomedicine Group Plans Grand Opening of its New Shanghai FacilityBy Nasdaq OMXSep 22, 2017, 12:40 PM UTC
BusinessCellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Technology Laboratory to Develop Control Processes for the Manufacture of CAR-T and Stem Cell TherapiesBy Nasdaq OMXApr 10, 2017, 12:08 PM UTC
BusinessCellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Technology Laboratory to Develop Control Processes for the Manufacture of CAR-T and Stem Cell TherapiesBy Nasdaq OMXApr 10, 2017, 12:08 PM UTC
BusinessCellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Technology Laboratory to Develop Control Processes for the Manufacture of CAR-T and Stem Cell TherapiesBy Nasdaq OMXApr 10, 2017, 12:08 PM UTC
BusinessCellular Biomedicine Group (CBMG) Announces Completion of Wuxi GMP Facility ExpansionBy Nasdaq OMXMar 30, 2017, 12:49 PM UTC
